FTC, FDA warn sellers of questionable opioid treatment products
There’s one thing people struggling with opioid addiction need: the facts. And there’s something that can hinder their recovery and perhaps even lead to relapse: unproven treatments promoted with deceptive advertising claims. Partnering with federal health agencies, the FTC has announced efforts related to both issues – and there are steps your business can take to lend a hand. The FTC and SAMHSA (HHS’ Substance Abuse and Mental Health Services...